Fifth Third Bancorp
KYNB

Fifth Third Bancorp’s Kyntra Bio KYNB Stock Holding History

Fifth Third Bancorp’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2
Closed -$2K – 2242
2019
Q3 		$2K Buy
+2
New +$2.2K ﹤0.01% 2049
2016
Q3 		– Sell
-64
Closed -$26K – 2247
2016
Q2 		$26K Sell
64
-35
-35% -$16K ﹤0.01% 1487
2016
Q1 		$53K Sell
99
-83
-46% -$41.4K ﹤0.01% 1305
2015
Q4 		$139K Hold
182
– – ﹤0.01% 1052
2015
Q3 		$100K Buy
182
+40
+28% +$24.2K ﹤0.01% 1156
2015
Q2 		$84K Buy
+142
New +$82.6K ﹤0.01% 1255

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fifth Third Bancorp's KYNB Position: Q4 2019 in Review

Fifth Third Bancorp sold out of Kyntra Bio (KYNB) in Q4 2019, closing a stake of 2 shares — an estimated $2K sold.

Fifth Third Bancorp first reported a position in KYNB in Q2 2015 and held it in 6 quarters. The position peaked at $139K in Q4 2015. 213 funds tracked by Wall St. Rank hold KYNB as of Q4 2019.

  • Fifth Third Bancorp reported no remaining Kyntra Bio position as of Q4 2019 after selling out during the quarter.
  • Fifth Third Bancorp sold 2 Kyntra Bio shares in Q4 2019, an estimated $2K.
  • Fifth Third Bancorp first reported a position in Kyntra Bio in Q2 2015 and held it in 6 quarters.
  • Fifth Third Bancorp's Kyntra Bio position peaked at $139K in Q4 2015.
  • 213 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2019.

Based on Fifth Third Bancorp's 13F filing for Q4 2019, filed 14 Feb 2020.